235 related articles for article (PubMed ID: 15993357)
1. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
Meier M; Kaiser T; Herrmann A; Knueppel S; Hillmann M; Koester P; Danne T; Haller H; Fliser D; Mischak H
J Diabetes Complications; 2005; 19(4):223-32. PubMed ID: 15993357
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis for the assessment of diabetic renal damage in humans.
Mischak H; Kaiser T; Walden M; Hillmann M; Wittke S; Herrmann A; Knueppel S; Haller H; Fliser D
Clin Sci (Lond); 2004 Nov; 107(5):485-95. PubMed ID: 15281910
[TBL] [Abstract][Full Text] [Related]
3. Proteomic identification of urinary biomarkers of diabetic nephropathy.
Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
[TBL] [Abstract][Full Text] [Related]
4. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
[TBL] [Abstract][Full Text] [Related]
6. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases.
Julian BA; Wittke S; Novak J; Good DM; Coon JJ; Kellmann M; Zürbig P; Schiffer E; Haubitz M; Moldoveanu Z; Calcatera SM; Wyatt RJ; Sýkora J; Sládková E; Hes O; Mischak H; McGuire BM
Electrophoresis; 2007 Dec; 28(23):4469-83. PubMed ID: 18004714
[TBL] [Abstract][Full Text] [Related]
7. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
8. Exercise induced proteinuria as an early indicator of diabetic nephropathy.
Agarwal RP; Thanvi I; Vachhani G; Kochar DK; Rastogi A
J Assoc Physicians India; 1998 Sep; 46(9):772-4. PubMed ID: 11229244
[TBL] [Abstract][Full Text] [Related]
9. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
Peczyńska J; Urban M; Głowińska B; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
[TBL] [Abstract][Full Text] [Related]
10. [Microalbuminuria: theoretical bases and new applications].
Airoldi G; Campanini M
Recenti Prog Med; 1993 Mar; 84(3):210-24. PubMed ID: 8465103
[TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M
Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
[TBL] [Abstract][Full Text] [Related]
12. Microalbuminuria--a marker of the risk of developing nephropathy in insulin-dependent diabetes.
Dryáková M; Englis M; Bartos V; Rozprimová L; Sidlová A; Malý J
Czech Med; 1989; 12(3):181-8. PubMed ID: 2509176
[TBL] [Abstract][Full Text] [Related]
13. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
14. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
15. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.
Wang Y; Ng MC; So WY; Ma R; Ko GT; Tong PC; Chan JC
Nephrol Dial Transplant; 2005 Dec; 20(12):2733-8. PubMed ID: 16141456
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
17. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
De Muro P; Fresu P; Formato M; Tonolo G; Mameli M; Maioli M; Sanna GM; Cherchi GM
J Nephrol; 2002; 15(3):290-6. PubMed ID: 12113601
[TBL] [Abstract][Full Text] [Related]
18. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
19. Unchanged incidence of diabetic nephropathy in Type 1 diabetes: a nation-wide study in Iceland.
Tryggvason G; Indridason OS; Thorsson AV; Hreidarsson AB; Palsson R
Diabet Med; 2005 Feb; 22(2):182-7. PubMed ID: 15660736
[TBL] [Abstract][Full Text] [Related]
20. Proteome analysis of serum from type 2 diabetics with nephropathy.
Kim HJ; Cho EH; Yoo JH; Kim PK; Shin JS; Kim MR; Kim CW
J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
